Document is current
Any future updates will be listed below
-
Authors
Lautenbacher, Ludwig https://orcid.org/0000-0002-1540-5911
Yang, Kevin L. https://orcid.org/0000-0002-8569-4579
Kockmann, Tobias https://orcid.org/0000-0002-1847-885X
Panse, Christian https://orcid.org/0000-0003-1975-3064
Gabriel, Wassim https://orcid.org/0000-0001-6440-9794
Bold, Dulguun
Kahl, Elias
Chambers, Matthew
MacLean, Brendan X. https://orcid.org/0000-0002-9575-0255
Li, Kai https://orcid.org/0000-0002-0810-2437
Yu, Fengchao https://orcid.org/0000-0002-7695-3698
Searle, Brian C. https://orcid.org/0000-0001-8760-6731
Wilburn, Damien Beau
Shahneh, Mohammad Reza Zare https://orcid.org/0000-0002-5760-3190
Hong, Yuhui https://orcid.org/0000-0002-5647-9714
Tang, Haixu https://orcid.org/0000-0001-8963-8155
Wang, Mingxun https://orcid.org/0000-0001-7647-6097
Gabriels, Ralf https://orcid.org/0000-0002-1679-1711
Bouwmeester, Robbin https://orcid.org/0000-0001-6807-7029
Devreese, Robbe https://orcid.org/0000-0002-3432-1502
Angelis, Jesse https://orcid.org/0009-0004-8209-3112
Sabidó, Eduard https://orcid.org/0000-0001-6506-7714
Schmidt, Tobias K. https://orcid.org/0000-0002-1883-6514
Nesvizhskii, Alexey I. https://orcid.org/0000-0002-2806-7819
Wilhelm, Mathias https://orcid.org/0000-0002-9224-3258
- License Information
-
More Information
Article History
Received: 20 November 2024
Accepted: 29 September 2025
First Online: 11 November 2025
Competing interests
: A.I.N. is the Founder of Fragmatics and serves on the scientific advisory boards of Protai Bio, Infinitopes, and Mobilion Systems. A.I.N. is also a paid consultant for Novartis. A.I.N., F.Y., and K.L. have a financial interest due to the licensing of MSFragger, IonQuant, and diaTracer to commercial entities. Mi.W. is a co-founder of Ometa Labs LLC. B.C.S. is a founder and shareholder in Proteome Software, which operates in the field of proteomics. The Searle Lab at the Ohio State University has a sponsored research agreement with Thermo Fisher Scientific. T.S. is a co-founder, shareholder, and employee of MSAID GmbH, a company that develops software for proteomics. M.W. is a co-founder and shareholder of MSAID GmbH and a scientific advisor of Momentum Biotechnologies, but he has no operational role in either company. The other authors have no competing interests to declare.
